GlassScriptPhysician profile
Heather M Bolinger
NPI 1396184081
$2,007.43
in general payments reported to CMS, 2019-2025
17 companies · $633 in 2025
The $633 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $350 · 2023: $151 · 2024: $630 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,413.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $457.98 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $396.16 | 2022-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $332.33 | 2021-2025 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $299.05 | 2025 | Jornay Pm |
| Novo Nordisk INC | $98.15 | 2024 | Wegovy |
| Merck Sharp & Dohme LLC | $79.79 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi Pasteur INC. | $64.39 | 2022-2025 | |
| Tris Pharma INC | $62.62 | 2021-2025 | Onyda Xr |
| Sanofi-Aventis U.S. LLC | $38.53 | 2024-2025 | |
| Adlon Therapeutics L.P. | $33.63 | 2021 | |
| Nevro Corp. | $25.89 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.60 | 2021 | |
| Acadia Pharmaceuticals INC | $24.95 | 2024 | Daybue |
| Pfizer INC. | $23.14 | 2025 | |
| Cranial Technologies, INC | $18.79 | 2025 | Doc Band |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.57 | 2023 | Flumist Quadrivalent |
| Genentech USA, INC. | $7.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Bolinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.